Taking a Multivitamin Could Slow some Signs of Aging, New Study Suggests

Why It Matters

If validated, multivitamins could become a low‑cost strategy to modestly extend healthspan, influencing both consumer choices and supplement industry positioning.

Key Takeaways

• Daily multivitamin slowed epigenetic clocks modestly
• Study involved 958 adults aged 60+ for two years
• Slowing effect measured 1.5–2 months per year
• Not all epigenetic clocks showed significant change
• Researchers call for more trials to confirm benefits

Pulse Analysis

Multivitamins dominate the U.S. supplement market, yet scientific consensus on their health impact remains fragmented. Unlike pharmaceuticals, these products are not FDA‑approved for disease prevention, and most claims rely on observational data. The rarity of a double‑blind, placebo‑controlled trial in this space marks a pivotal step toward evidence‑based nutrition, offering a rare glimpse into how a widely consumed product might interact with molecular aging mechanisms.

The Nature Medicine study enrolled nearly a thousand seniors and administered a standard multivitamin‑multimineral formula for two years. Researchers measured DNA methylation‑based epigenetic clocks, focusing on PCPhenoAge and PCGrimAge, which showed a deceleration of roughly 1.5‑2 months of biological aging per calendar year. However, three additional clocks showed no statistical shift, underscoring the modest and selective nature of the effect. The trial controlled for baseline health characteristics but could not fully account for participants’ diet, exercise, or other lifestyle factors that also influence epigenetic aging.

These findings spark both optimism and caution. For consumers, the prospect of a simple pill that nudges biological age could reinforce multivitamin use, especially among older adults seeking to preserve functional capacity. For the supplement industry, the data provide a potential scientific foothold for marketing claims, albeit tempered by the need for replication and broader age‑range studies. Ultimately, the research highlights the importance of rigorous clinical designs in nutrition science and suggests that any longevity benefit from multivitamins is likely incremental rather than transformative, pending further validation.